Grenada vs Micronesia, Federated States of: Protecting minority investors: Ease of shareholder suits index (0-10)
Grenada
80
in 2019
Micronesia, Federated States of
80
in 2019
Grenada rank
24th
Micronesia, Federated States of rank
24th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Grenada
- Micronesia, Federated States of
How they compare
Grenada currently reports 80 against 80 in Micronesia, Federated States of, a difference of 0.
Across all 7 years both countries report, Micronesia, Federated States of has been ahead every year.
Grenada ranks 24th and Micronesia, Federated States of ranks 24th of 191 countries.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Grenada or Micronesia, Federated States of?
- Grenada, at 80 against 80 in Micronesia, Federated States of as of 2019.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Grenada and Micronesia, Federated States of?
- 0, with Grenada ahead.
- How many years of comparable data are there for Grenada and Micronesia, Federated States of?
- 7 years are reported by both, from 2013 to 2019.
- How do Grenada and Micronesia, Federated States of rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Grenada ranks 24th and Micronesia, Federated States of ranks 24th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB15-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB15-20 studies.